Ultra-RT Ultratrutide™
Ultra-RT Ultratrutide™ is an advanced experimental quad-agonist peptide developed for metabolic pathway research, combining GLP-1, GIP, Glucagon, and Ghrelin re
Pricing and ordering are available to approved research accounts.
🔒 Secure checkout💳 Powered by XRay Payment
Ultra-RT Ultratrutide™ – Advanced Quad-Agonist Peptide for Metabolic Pathway Research
Ultra-RT Ultratrutide™ is an advanced quad-agonist peptide built for metabolic pathway research. It combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity into one research compound. As a result, labs can study several metabolic and hormone pathways at the same time.
Because of this multi-pathway design, researchers can explore energy use, nutrient balance, metabolic control, and lean tissue signaling in one model.
In addition, Ultra-RT Ultratrutide™ goes beyond standard incretin-based compounds by adding Ghrelin receptor activity. Therefore, it gives researchers a broader way to study how the body balances energy use and tissue support during metabolic changes.
Mechanisms of Action
GLP-1 Receptor Activity
GLP-1 receptor activity supports research into satiety signals, glycemic balance, and metabolic control.
GIP Receptor Activity
Likewise, GIP receptor activity helps researchers study insulin signaling, nutrient use, and metabolic efficiency.
Glucagon Receptor Activity
In addition, Glucagon receptor activity allows for research into thermogenesis, liver energy output, and fat metabolism pathways.
Ghrelin Receptor Activity
Finally, Ghrelin receptor agonism targets GHS-R1a pathways and supports research into growth hormone signaling and lean tissue support.
Research Applications
Researchers often use this quad-agonist peptide in studies involving:
• Multi-pathway metabolic optimization
• Energy use and nutrient balance
• Lean tissue signaling during caloric restriction
• Body composition pathway analysis
• Hormone response during metabolic shifts
Why Researchers Choose This Quad-Agonist Peptide
Most traditional metabolic research compounds focus only on appetite and glucose pathways. However, Ultra-RT Ultratrutide™ adds Ghrelin receptor activity for a broader research profile.
Because of this added pathway, researchers can study metabolic, anabolic, and recovery-related signaling in one compound.
Overall, Ultra-RT Ultratrutide™ offers labs a next-generation tool for advanced metabolic pathway research.
Research Use Notice
Ultra-RT Ultratrutide™ is intended strictly for laboratory research and analytical purposes only. It is not for human or veterinary use.
Ultra-RT Ultratrutide™ is an advanced quad-agonist peptide built for metabolic pathway research. It combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity into one research compound. As a result, labs can study several metabolic and hormone pathways at the same time.
Because of this multi-pathway design, researchers can explore energy use, nutrient balance, metabolic control, and lean tissue signaling in one model.
In addition, Ultra-RT Ultratrutide™ goes beyond standard incretin-based compounds by adding Ghrelin receptor activity. Therefore, it gives researchers a broader way to study how the body balances energy use and tissue support during metabolic changes.
Mechanisms of Action
GLP-1 Receptor Activity
GLP-1 receptor activity supports research into satiety signals, glycemic balance, and metabolic control.
GIP Receptor Activity
Likewise, GIP receptor activity helps researchers study insulin signaling, nutrient use, and metabolic efficiency.
Glucagon Receptor Activity
In addition, Glucagon receptor activity allows for research into thermogenesis, liver energy output, and fat metabolism pathways.
Ghrelin Receptor Activity
Finally, Ghrelin receptor agonism targets GHS-R1a pathways and supports research into growth hormone signaling and lean tissue support.
Research Applications
Researchers often use this quad-agonist peptide in studies involving:
• Multi-pathway metabolic optimization
• Energy use and nutrient balance
• Lean tissue signaling during caloric restriction
• Body composition pathway analysis
• Hormone response during metabolic shifts
Why Researchers Choose This Quad-Agonist Peptide
Most traditional metabolic research compounds focus only on appetite and glucose pathways. However, Ultra-RT Ultratrutide™ adds Ghrelin receptor activity for a broader research profile.
Because of this added pathway, researchers can study metabolic, anabolic, and recovery-related signaling in one compound.
Overall, Ultra-RT Ultratrutide™ offers labs a next-generation tool for advanced metabolic pathway research.
Research Use Notice
Ultra-RT Ultratrutide™ is intended strictly for laboratory research and analytical purposes only. It is not for human or veterinary use.
📄 Certificates of Analysis 5
Independent third-party test results for this product, by lot. Open the certificate for the lot printed on your vial.
Glucagon Peptides
Home page
Lab Tested Products
Research Peptide
Retatrutide
SP-1 and Amylin Research
Reviews
★
No reviews yet
Be the first to share your thoughts on this product.
Write a review
★★★★★
